Intellectual Property - October 21, 2025
Alligator Bioscience granted US patent
The United States Patent and Trademark Office has granted a patent covering the composition of matter of ATOR-4066, the company’s bispecific antibody targeting CD40 and CEACAM5.
Intellectual Property - October 1, 2025
Neogap granted Chinese patent
Neogap Therapeutics has been granted a Chinese patent for its method of expanding tumour-specific T cells – a key component of the company’s therapeutic approach.
Intellectual Property - September 26, 2025
Scandinavian Real Heart receives patent approval in Japan
The company has been granted patent approval by the Japan Patent Office (JPO) concerning the automatic control of Realheart TAH.
Biotech Business - September 23, 2025
Elicera’s US patent application still under examination
The company has announced that the ongoing patent application for the iTANK platform in the United States is still under examination by the United States Patent and Trademark Office (USPTO).
Intellectual Property - August 18, 2025
Faron announces extension to key patent family with new US patent granted
Faron Pharmaceuticals has announced that the United States Patent and Trademark Office has granted a new US Patent for treatment of Clever-1 positive cancers with bexmarilimab and related structures that would bind to Clever-1 molecule for the wanted re-programming effect.
Intellectual Property - August 4, 2025
VibroSense Dynamics obtains biomarker patent
VibroSense Dynamics has received an Intention to Grant from the European Patent Office (EPO) regarding a patent on a biomarker to predict the risk of developing permanent nerve damage after cancer treatment with chemotherapy.
